UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES
EXCHANGE ACT OF 1934
For
the month of September 2025
Commission
File Number 001-40517
BON
NATURAL LIFE LIMITED
(Translation
of registrant’s name into English)
Room
601, Block C, Gazelle Valley, No.69, Jinye Road
High-Tech
Zone, Xi’an, Shaanxi, China
People’s
Republic of China
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form
40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Note:
Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report
to security holders.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Note:
Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that
the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated,
domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on
which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to
be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the
subject of a Form 6-K submission or other Commission filing on EDGAR.
Supply
Agreement
On
September 1, 2025, our subsidiary Xi’an App-Chem Bio (Tech) Co., Ltd (“App-Chem”) entered into a Sales Cooperation
Agreement (the “Agreement”) with Beijing Huahai Keyuan Technology Co., Ltd (“Huahai Keyuan”). Under the Agreement,
App-Chem grants Huahai Keyuan the non-exclusive right to market, distribute and sell App-Chem’s
second-generation Apple Series Products, a line of natural weight management and metabolic health products formulated with apple polyphenols
and plant proteins (collectively, the “Products”) in the Chinese market. The term of the Agreement is twenty-four (24) months.
App-Chem
will be responsible for all research and development, production and quality control such that the Products are compliant with applicable
national standards.
Pursuant
to the Agreement Huahai Keyuan has guaranteed aggregate sales of no less than US$18,000,000 over the term.
In
the event the Products fail to conform to the agreed quality standards, App-Chem shall be responsible for all testing expenses, as well
as any costs associated with returns and exchanges.
Products
will be transported to such sites as designated by Huahai Keyuan.
App-Chem
must receive full payment from Huahai Keyuan for any Products before they are dispatched.
If
either party breaches the Agreement and fails to cure such breach within thirty (30) working days after receipt of written notice from
the non-breaching party, the non-breaching party may terminate the Agreement. The Agreement may also be terminated at any time by the
mutual written consent of both parties. Either party that terminates the Agreement without justifiable reasons (as defined in the Agreement)
or fails to fulfill its obligations under the Agreement shall compensate the other party with a liquidated damages equivalent to 15%
of the total Agreement amount. Any lawsuits must be filed in a court located in the People’s Republic of China.
The
foregoing is a summary of the material terms of the Agreement. The Agreement contains additional terms, covenants and conditions and
should be reviewed in its entirety for additional information.
Exhibits
The
following exhibits are included in this Form 6-K:
| Exhibit
No. |
|
Description
of Exhibit |
10.1 |
|
Translation of Sales Cooperation Agreement with Beijing Huahai Keyuan Technology Co., Ltd. |
| 99.1 |
|
Press Release dated September 9, 2025 |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| Date: September 9, 2025 |
Bon Natural Life Limited |
| |
|
|
| |
By: |
/s/ Yongwei
Hu |
| |
|
Yongwei Hu |
| |
|
Chairman and Chief Executive Officer |
